233 related articles for article (PubMed ID: 33964976)
1. Clinical characteristics and prognosis of patients with isolated thrombotic vs. obstetric antiphospholipid syndrome: a prospective cohort study.
Jiang H; Wang CH; Jiang N; Li J; Wu CY; Wang Q; Li MT; Tian XP; Zhao JL; Zhao Y; Zeng XF
Arthritis Res Ther; 2021 May; 23(1):138. PubMed ID: 33964976
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
[TBL] [Abstract][Full Text] [Related]
3. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
[TBL] [Abstract][Full Text] [Related]
4. The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics.
Tonello M; Calligaro A; Favaro M; Del Ross T; Veronese P; Salvan E; Gervasi MT; Ruffatti A
Arch Gynecol Obstet; 2021 Feb; 303(2):455-461. PubMed ID: 32880711
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.
Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Hoxha A; Tincani A; Nalli C; Marozio L; Maina A; Espinosa G; Ríos-Garcés R; Cervera R; Carolis S; Monteleone G; Latino O; Udry S; LLurba E; Garrido-Gimenez C; Trespidi L; Gerosa M; Chighizola CB; Rovere-Querini P; Canti V; Mayer-Pickel K; Tabacco S; Arnau A; Trapé J; Ruiz-Hidalgo D; Sos L; Farran-Codina I;
Rheumatology (Oxford); 2020 Jun; 59(6):1306-1314. PubMed ID: 31580459
[TBL] [Abstract][Full Text] [Related]
6. Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome.
Zhou Z; You Y; Wang F; Sun Y; Teng J; Liu H; Cheng X; Su Y; Shi H; Hu Q; Chi H; Jia J; Wan L; Liu T; Wang M; Shi C; Yang C; Ye J
Front Immunol; 2021; 12():702425. PubMed ID: 34489952
[TBL] [Abstract][Full Text] [Related]
7. Long Term Follow up of Patients With Primary Obstetric Antiphospholipid Syndrome.
Niznik S; Rapoport MJ; Avnery O; Lubetsky A; Shavit R; Ellis MH; Agmon-Levin N
Front Pharmacol; 2022; 13():824775. PubMed ID: 35529433
[No Abstract] [Full Text] [Related]
8. Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study.
Pablo RD; Cacho PM; López-Hoyos M; Calvo-Río V; Riancho-Zarrabeitia L; Martínez-Taboada VM
Clin Rev Allergy Immunol; 2022 Apr; 62(2):354-362. PubMed ID: 34216367
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibody carriers and patients with quiescent antiphospholipid syndrome show persistent subclinical complement activation.
Zen M; Tonello M; Favaro M; Del Ross T; Calligaro A; Giollo A; Vesentini F; Gennaio IA; Arru F; Ruffatti A; Doria A
Rheumatology (Oxford); 2024 May; 63(6):1733-1738. PubMed ID: 37774001
[TBL] [Abstract][Full Text] [Related]
10. Obstetric antiphospholipid syndrome carries an increased lifetime risk for obstetric and thrombotic complications-a population-based study.
Rhein AK; Rabinovich A; Abuhasira R; Lubaton-Barshishat S; Erez O
Res Pract Thromb Haemost; 2024 May; 8(4):102430. PubMed ID: 38798792
[TBL] [Abstract][Full Text] [Related]
11. Does seronegative obstetric APS exist? "pro" and "cons".
Conti F; Andreoli L; Crisafulli F; Mancuso S; Truglia S; Tektonidou MG
Autoimmun Rev; 2019 Dec; 18(12):102407. PubMed ID: 31639518
[TBL] [Abstract][Full Text] [Related]
12. Anti-β2GPI domain 1 antibodies stratify high risk of thrombosis and late pregnancy morbidity in a large cohort of Chinese patients with antiphospholipid syndrome.
Liu T; Gu J; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Zhou Z; Jia J; Wang Z; Zhou J; Norman GL; Wang X; Yang C; Shi H
Thromb Res; 2020 Jan; 185():142-149. PubMed ID: 31816554
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study.
Qi W; Zhao J; Huang C; Jiang N; Li J; Wu C; Zhang S; Hu C; Xu D; Wang Q; Li M; Tian X; Zhao Y; Zeng X
Arthritis Res Ther; 2022 Jun; 24(1):140. PubMed ID: 35690831
[TBL] [Abstract][Full Text] [Related]
14. Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study.
Laurent C; Ricard L; Nguyen Y; Boffa JJ; Rondeau E; Gerotziafas G; Elalamy I; Deriaz S; De Moreuil C; Planche V; Johanet C; Millot F; Fain O; Mekinian A
RMD Open; 2023 Mar; 9(1):. PubMed ID: 37001919
[TBL] [Abstract][Full Text] [Related]
15. Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.
Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; LLurba E; Ruffatti A; Tincani A; Lefkou E; Bertero MT; Espinosa G; de Carolis S; Rovere-Querini P; Lundelin K; Picardo E; Mekinian A;
Med Clin (Barc); 2018 Sep; 151(6):215-222. PubMed ID: 29274674
[TBL] [Abstract][Full Text] [Related]
16. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.
Ma J; Song H; Wei M; He Y
Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509
[TBL] [Abstract][Full Text] [Related]
18. Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study).
Bazzan M; Vaccarino A; Stella S; Sciascia S; Montaruli B; Bertero MT; Carignola R; Roccatello D;
Lupus; 2016 Apr; 25(5):479-85. PubMed ID: 26657216
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of pregnancy complications and treatment in obstetric antiphospholipid syndrome in China.
Zhou Z; Teng J; Sun Y; Liu H; Cheng X; Su Y; Yang C; Ye J
Clin Rheumatol; 2019 Nov; 38(11):3161-3168. PubMed ID: 31290022
[TBL] [Abstract][Full Text] [Related]
20. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
Forastiero R
Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
